Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

ClinicalTrials.gov ID: NCT01516541

Public ClinicalTrials.gov record NCT01516541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Effect of Dalcetrapib 600 mg on Cardiovascular (CV) Events in Adult Patients With Stable Coronary Heart Disease (CHD), CHD Risk Equivalents or at Elevated Risk for Cardiovascular Disease (CVD).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the potential of dalcetrapib to reduce cardiovascular morbidity and mortality in patients with stable coronary heart disease (CHD), with CHD risk equivalents or at elevated risk for cardiovascular disease. Eligible patients will be randomized to receive either dalcetrapib 600 mg orally daily or placebo orally daily, on a background of contemporary, guidelines-based medical care. Anticipated time on study treatment is 4 years.

Study identification

NCT ID
NCT01516541
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
2,220 participants

Conditions and interventions

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2012 (Type not available)
Primary completion
Jul 2012 (Actual)
Completion
Jul 2012 (Actual)
Last update posted
Nov 2, 2016

2012

United States locations

U.S. sites
121
U.S. states
31
U.S. cities
115
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294-0007 —
Not listed Huntsville Alabama 35801 —
Not listed Anaheim California 92801 —
Not listed Fullerton California 92835 —
Not listed San Diego California 92103 —
Not listed Santa Ana California 92704 —
Not listed Santa Rosa California 95405 —
Not listed Torrance California 90503 —
Not listed Torrance California 90509 —
Not listed Colorado Springs Colorado 80909 —
Not listed Denver Colorado 80218 —
Not listed Lonetree Colorado 80124 —
Not listed Bridgeport Connecticut 06606 —
Not listed Hartford Connecticut 06102 —
Not listed Boynton Beach Florida 33472 —
Not listed Daytona Beach Florida 32114 —
Not listed Daytona Beach Florida 32117 —
Not listed Fort Myers Florida 33907 —
Not listed Jacksonville Florida 32216 —
Not listed Panama City Florida 32401 —
Not listed Plantation Florida 33317 —
Not listed Port Charlotte Florida 33952 —
Not listed Tallahassee Florida 32308 —
Not listed Tampa Florida 33613 —
Not listed West Palm Beach Florida 33401 —
Not listed Covington Georgia 30014 —
Not listed Cumming Georgia 30041 —
Not listed Decatur Georgia 30033 —
Not listed Aurora Illinois 60504 —
Not listed Rock Island Illinois 61201 —
Not listed Winfield Illinois 60190 —
Not listed Elkhart Indiana 46617 —
Not listed Hammond Indiana 46320-1942 —
Not listed Indianapolis Indiana 46237 —
Not listed Indianapolis Indiana 46250 —
Not listed Muncie Indiana 47303 —
Not listed South Bend Indiana 46601 —
Not listed Overland Park Kansas 66215 —
Not listed Louisville Kentucky 40205 —
Not listed Alexandria Louisiana 71301 —
Not listed Bangor Maine 04401 —
Not listed Beltsville Maryland 20705 —
Not listed Salisbury Maryland 21804 —
Not listed Boston Massachusetts 02111 —
Not listed Haverhill Massachusetts 01830 —
Not listed Hyannis Massachusetts 02601 —
Not listed North Dartmouth Massachusetts 02747 —
Not listed Jackson Michigan 49201 —
Not listed Kalamazoo Michigan 49048 —
Not listed Marquette Michigan 49855 —
Not listed Midland Michigan 48670 —
Not listed Rochester Hills Michigan 48307 —
Not listed Saginaw Michigan 48602 —
Not listed Ypsilanti Michigan 48197 —
Not listed Rochester Minnesota 55905-0001 —
Not listed Saint Cloud Minnesota 56303 —
Not listed Chesterfield Missouri 63017 —
Not listed Columbia Missouri 65201 —
Not listed Kansas City Missouri 64111 —
Not listed Kalispell Montana 59901 —
Not listed Nashua New Hampshire 03060 —
Not listed Camden New Jersey 08103 —
Not listed Haddon Heights New Jersey 08035 —
Not listed Mine Hill New Jersey 07803 —
Not listed Wayne New Jersey 07470 —
Not listed Westwood New Jersey 07675 —
Not listed Albany New York 12206-1098 —
Not listed Albany New York 12211 —
Not listed Buffalo New York 14215 —
Not listed Cortlandt Manor New York 10567 —
Not listed Poughkeepsi New York 12601 —
Not listed Saratoga Springs New York 12866 —
Not listed Smithtown New York 11787 —
Not listed Syracuse New York 13202 —
Not listed The Bronx New York 10461 —
Not listed Troy New York 12180 —
Not listed Asheville North Carolina 28803 —
Not listed Durham North Carolina 27710 —
Not listed Elizabeth City North Carolina 27909 —
Not listed Hickory North Carolina 28602 —
Not listed Morehead City North Carolina 28557 —
Not listed Rocky Mount North Carolina 27804 —
Not listed Statesville North Carolina 28625 —
Not listed Wilmington North Carolina 28401 —
Not listed Fargo North Dakota 58103 —
Not listed Cincinnati Ohio 45227 —
Not listed Cleveland Ohio 44195 —
Not listed Mansfield Ohio 44827 —
Not listed Mentor Ohio 44060 —
Not listed Thornville Ohio 43076 —
Not listed Toledo Ohio 43623 —
Not listed Zanesville Ohio 43701 —
Not listed Allentowm Pennsylvania 18105 —
Not listed Altoona Pennsylvania 16602 —
Not listed Camp Hill Pennsylvania 17011 —
Not listed Doylestown Pennsylvania 18901 —
Not listed Erie Pennsylvania 16502 —
Not listed Erie Pennsylvania 16550 —
Not listed Langhorne Pennsylvania 19047 —
Not listed Lansdale Pennsylvania 19446 —
Not listed North Wales Pennsylvania 19454-2053 —
Not listed Philadelphia Pennsylvania 19114 —
Not listed Philadelphia Pennsylvania 19153 —
Not listed Pottstown Pennsylvania 19464 —
Not listed Tipton Pennsylvania 16684 —
Not listed West Chester Pennsylvania 19380 —
Not listed Anderson South Carolina 29621 —
Not listed Greer South Carolina 29651 —
Not listed Rapid City South Dakota 57701 —
Not listed Johnson City Tennessee 37604 —
Not listed Dallas Texas 75251 —
Not listed Humble Texas 77338 —
Not listed Odessa Texas 79761 —
Not listed Tyler Texas 75701 —
Not listed Provo Utah 84004 —
Not listed Charlottesville Virginia 22908 —
Not listed Danville Virginia 24541-4160 —
Not listed Lynchburg Virginia 24501 —
Not listed Manassas Virginia 20109 —
Not listed Richmond Virginia 23249 —
Not listed Winchester Virginia 22601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 120 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01516541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01516541 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →